Skip to main content
. 2016 Mar 1;11(3):e0149910. doi: 10.1371/journal.pone.0149910

Table 1. Clinical data.

AF(-)Thromb(-) AF(+)Thromb(-) AF(+)Thromb(+) P value
(n = 19) (n = 57) (n = 14)
Age, (years) 49.00±11.22 54.53 ±8.85 55.50 ± 6.88 0.13
Male, (n) 9 16 5 0.30
Hypertension, (n) 2 6 1 0.93
Diabetes mellitus, (n) 1 7 1 0.70
CAD, (n) 0 8 2 0.24
Pulmonary hypertension, (n) 14 49 14 0.09
Congestive heart failure, (n) 1 4 0 0.82
Stroke/TIA, (n) 1 5 4 0.09
Smoke, (n) 2 3 0 0.44
Alcohol abuse, (n) 1 2 0 0.70
Pre-operation data, (n)
    NYHA class I/II/III/IV 1/3/13/2 0/9/44/4 0/1/13/0 0.42
    Mitral stenosis 14 42 14 0.10
    Mitral regurgitation 19 57 14 NS
    Mitral prolapse 0 0 0 NS
    Aorta stenosis 5 7 3 0.32
    Aorta regurgitation 13 31 5 0.19
    Tricuspid regurgitation 16 46 13 0.61
CRP, (mg/L) 3.7±2.61 7.52 ±14.73 9.40 ± 12.82 0.89
BUN, (mmol/L) 5.36±1.52 6.34 ±2.30 6.52 ± 1.84 0.29
Cr, (mmol/L) 65.97±28.74 70.46 ±26.34 73.00 ± 12.34 0.06
BNP, (pg/ml) 112.35±92.71 305.61 ±297.46 307.00 ± 170.73 0.06
PT, (s) 13.64±4.13 15.38 ±5.78 14.35 ± 2.16 0.05
APTT, (s) 49.70±74.95 35.09 ±11.02 39.51 ± 18.80 0.55
INR 1.07±0.25 1.31 ±0.55 1.17 ± 0.23 0.02